iX Biopharma Ltd. (SG:42C) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
iX Biopharma Ltd. has announced the formation of a new Audit and Risk Committee by merging its Audit Committee and Risk Management Committee. This restructuring aims to streamline the roles and responsibilities of its board members, enhancing governance efficiency. Additionally, the company has reconstituted its board committees following the retirement of Independent Director Ms. Angeline Tham.
For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.